期刊文献+

用流式细胞测定仪测定AITD患者TRAb 被引量:4

FLOW CYTOMETRIC ANALYSES OF TRAb WITH AITD
下载PDF
导出
摘要 以人工重组TSH受体表达的中国仓鼠卵细胞(CHO-TSHR)为靶细胞,用流式细胞(FACS)测定技术,对45例自身免疫性甲状腺病(AITD)患者血清中SH受体抗体(TRAb)进行测定。结果显示:36例GD患者阳性细胞结合的百分数为1.9%~77.4%。阳性率为91.66%。其均值26.139%与正常人均值6.163%相比有显著性差异(P=0.0001)。9例桥本(HT)甲减患者5例阳性,阳性率为55.56%。证实以CHO-TSHR细胞为靶细胞用FACS进行TRAb汕测定不失为一种敏感简便的新方法。 Using Chinese hamster ovary(CHO) cells that express high numbers of TSH receptor (TSHR) on the surface, we studied bindingactivity of antibodies in patients' sera to the TSHRby flow cytometry. It showed thatthe binding activity of 36 sera from active Graves' disease patientswas. 1.9%~77. 4%, while 30 sera from normalsubjects was 0. 1% ~15. 1 %. The positive rate was91. 66%. The median binding activity in activeGraves' disease patients (26. 139% ) was significantly higher than that of normal subjects (6. 163%;P=0. 0001). We also studied 9 sera from Hoshimototyroiditis (HT). The positive rate was 55. 56%. Inconclusion, this method can be used to detect binding of antibodies to TSHR.
出处 《西安医科大学学报》 CSCD 1999年第1期115-117,共3页 Journal of Xi'an Medical University(Chinese)
关键词 甲状腺疾病 AITD 流式细胞仪 TSH受体抗体 TSH receptor antibodies (TRAb) flow cytometric analyses (FACS) Chinese hamster ovarycells-TSH receptor (CHO-TSHR) Gravea' disease (GD)
  • 相关文献

参考文献1

二级参考文献3

  • 1金世鑫,西安医科大学学报,1990年,2卷
  • 2白耀,中华内分泌代谢杂志,1987年,3卷,137页
  • 3胡仲懿,中华内科杂志,1984年,23卷,480页

共引文献1

同被引文献34

  • 1兰玲,施秉银.促甲状腺素受体抗体检测的临床意义[J].国外医学(内分泌学分册),2005,25(1):42-44. 被引量:12
  • 2兰玲,施秉银.促甲状腺素受体抗体检测技术的回顾与展望[J].国外医学(内分泌学分册),2005,25(1):45-47. 被引量:11
  • 3刘超,蒋须勤,陈家伟,覃又文,刘翠萍,张忠邦,张静馨.甲亢甲状腺细胞单层培养检测TSAb条件的探讨和临床应用[J].中华内分泌代谢杂志,1993,9(3):163-165. 被引量:14
  • 4Mizutori Y, Chen CR, MeLachlan SM, et al. The thyrotrepin receptor hinge region is not simply a scaffold for the Leueine - Rich Domain but contributes to ligand binding and signal transduction. Molecular Endocrinology. 2008,22(5) :1171.
  • 5Kohn LD, Harii N. Thyrotropin receptor autoantibodies (TSHRAbs) : epitopes, origins and clinical significance. Autoimmunity. 2003,36(6 -7) :331.
  • 6Morgenthaler NG, Ho SC, Minich WB. Stimulating and blocking TSH - receptor autoantibodies from patients with Graves's disease and antoimmune hypothyroidsm have very similar concentration, TSH - receptor affinity and binding sites. J Clin Endocrinol Metab. 2007,92(3 ) :1058.
  • 7Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves's disease. J Clin Endocrinol Metab. 1999,84(1) :90.
  • 8Villata D, Orunesu E, Tozzoli R, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotropin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol. 2004,57 (4) :378.
  • 9Pedersen IB, Knudsen N, Perrild H, et al. TSH - receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goiter: a comparison of two competitive binding assays. Clin Endocrinol. 2001,55(3) :381.
  • 10Massart C, Orgiazzi J, Maugendre D. Clinical vandity of a new commercial method for detection of TSH - receptor binding antibodies in sera from patients with Graves' disease treated with antithvroid drugs. Clin Chem Acta. 2001,304:39.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部